首页 > 最新文献

AJPM focus最新文献

英文 中文
Religious Service Attendance, COVID-19 Vaccine Attitudes, and COVID-19 Vaccination Status: A Vaccine Safety Datalink Member Survey, 2022–2023 宗教服务出席率、COVID-19疫苗态度和COVID-19疫苗接种状况:疫苗安全数据链成员调查,2022-2023
Pub Date : 2025-07-30 DOI: 10.1016/j.focus.2025.100404
Joshua T.B. Williams MD , Kate Kurlandsky BA , Kristin Breslin MPH , Hannah Cruz MPH , Amy Stein PhD , Jo Ann Shoup PhD , Liza M. Reifler MPH , Matthew F. Daley MD , Bruno Lewin MD, DTMH , Kristin Goddard MPH , Michelle L. Henninger PhD , Jennifer C. Nelson PhD , Gabriela Vazquez-Benitez PhD, MSC , Kayla E. Hanson MPH , Candace C. Fuller PhD, MPH , Simon J. Hambidge MD, PhD

Introduction

The intersections of religion and vaccination became visible early in the COVID-19 pandemic. Yet, initial pandemic data reporting associations between religiosity and COVID-19 vaccine hesitancy is nearly 5 years old and has methodologic limitations. The aim of this study was to examine the associations between religious service attendance, COVID-19 attitudes, and COVID-19 vaccination at the midpoint of the COVID-19 public health emergency.

Methods

A survey of Vaccine Safety Datalink members, purposefully sampled by race, ethnicity, language, and pregnancy status (N=2,856), was administered from November 2022 through February 2023. Data were analyzed through weighting and multivariable logistic regression.

Results

Overall, 960 people (33%) responded; 22.8% (95% CI=15.2%, 30.3%) identified as Catholic, and 21.7% (95% CI=14.6%, 28.9%) identified as just Christian. Overall, 28.1% (95% CI=19.4%, 36.8%) reported never attending services, whereas 19.0% (95% CI=12.3%, 25.7%) attended weekly or more often. Compared with never attending services, religious service attendance weekly or more often was associated with increasing bivalent COVID-19 Omicron booster vaccine hesitancy (p<0.01) and decreasing trust in the Centers for Disease Control and Prevention for COVID-19 or COVID-19 vaccine information (p=0.033). Self-reported COVID-19 vaccination ever (AOR=0.65; 95% CI=0.23, 1.84) or any bivalent COVID-19 Omicron booster vaccination (AOR=0.36; 95% CI=0.06, 2.20) were not associated with religious service attendance weekly or more often, compared with never attending services.

Conclusions

Observed associations between religious service attendance, vaccine attitudes, and trust in the Centers for Disease Control and Prevention encourage meaningfully redefining public health and faith community partnerships oriented toward COVID-19–related education and disease prevention.
在2019冠状病毒病大流行早期,宗教与疫苗接种的交集就显现出来了。然而,报告宗教信仰与COVID-19疫苗犹豫之间关联的初始大流行数据已有近5年的历史,并且存在方法上的局限性。本研究的目的是研究在COVID-19突发公共卫生事件中期,宗教服务出席率、COVID-19态度和COVID-19疫苗接种之间的关系。方法从2022年11月至2023年2月对疫苗安全数据链成员进行调查,有目的地按种族、民族、语言和妊娠状况进行抽样(N=2,856)。通过加权和多变量logistic回归对数据进行分析。结果共有960人(33%)回复;22.8% (95% CI=15.2%, 30.3%)认为自己是天主教徒,21.7% (95% CI=14.6%, 28.9%)认为自己只是基督徒。总体而言,28.1% (95% CI=19.4%, 36.8%)从不参加礼拜,而19.0% (95% CI=12.3%, 25.7%)每周或更频繁地参加礼拜。与从不参加礼拜相比,每周或更频繁参加宗教礼拜与二价COVID-19 Omicron增强疫苗犹豫增加(p<0.01)和对疾病控制与预防中心COVID-19或COVID-19疫苗信息的信任度降低相关(p=0.033)。自我报告的COVID-19疫苗接种(AOR=0.65; 95% CI=0.23, 1.84)或任何双价COVID-19 Omicron加强疫苗接种(AOR=0.36; 95% CI=0.06, 2.20)与每周或更频繁地参加宗教服务与从不参加宗教服务无关。观察到的宗教服务出席率、疫苗态度和对疾病控制与预防中心的信任之间的关联,鼓励有意义地重新定义面向covid -19相关教育和疾病预防的公共卫生和信仰社区伙伴关系。
{"title":"Religious Service Attendance, COVID-19 Vaccine Attitudes, and COVID-19 Vaccination Status: A Vaccine Safety Datalink Member Survey, 2022–2023","authors":"Joshua T.B. Williams MD ,&nbsp;Kate Kurlandsky BA ,&nbsp;Kristin Breslin MPH ,&nbsp;Hannah Cruz MPH ,&nbsp;Amy Stein PhD ,&nbsp;Jo Ann Shoup PhD ,&nbsp;Liza M. Reifler MPH ,&nbsp;Matthew F. Daley MD ,&nbsp;Bruno Lewin MD, DTMH ,&nbsp;Kristin Goddard MPH ,&nbsp;Michelle L. Henninger PhD ,&nbsp;Jennifer C. Nelson PhD ,&nbsp;Gabriela Vazquez-Benitez PhD, MSC ,&nbsp;Kayla E. Hanson MPH ,&nbsp;Candace C. Fuller PhD, MPH ,&nbsp;Simon J. Hambidge MD, PhD","doi":"10.1016/j.focus.2025.100404","DOIUrl":"10.1016/j.focus.2025.100404","url":null,"abstract":"<div><h3>Introduction</h3><div>The intersections of religion and vaccination became visible early in the COVID-19 pandemic. Yet, initial pandemic data reporting associations between religiosity and COVID-19 vaccine hesitancy is nearly 5 years old and has methodologic limitations. The aim of this study was to examine the associations between religious service attendance, COVID-19 attitudes, and COVID-19 vaccination at the midpoint of the COVID-19 public health emergency.</div></div><div><h3>Methods</h3><div>A survey of Vaccine Safety Datalink members, purposefully sampled by race, ethnicity, language, and pregnancy status (N=2,856), was administered from November 2022 through February 2023. Data were analyzed through weighting and multivariable logistic regression.</div></div><div><h3>Results</h3><div>Overall, 960 people (33%) responded; 22.8% (95% CI=15.2%, 30.3%) identified as Catholic, and 21.7% (95% CI=14.6%, 28.9%) identified as just Christian. Overall, 28.1% (95% CI=19.4%, 36.8%) reported never attending services, whereas 19.0% (95% CI=12.3%, 25.7%) attended weekly or more often. Compared with never attending services, religious service attendance weekly or more often was associated with increasing bivalent COVID-19 Omicron booster vaccine hesitancy (<em>p</em>&lt;0.01) and decreasing trust in the Centers for Disease Control and Prevention for COVID-19 or COVID-19 vaccine information (<em>p</em>=0.033). Self-reported COVID-19 vaccination ever (AOR=0.65; 95% CI=0.23, 1.84) or any bivalent COVID-19 Omicron booster vaccination (AOR=0.36; 95% CI=0.06, 2.20) were not associated with religious service attendance weekly or more often, compared with never attending services.</div></div><div><h3>Conclusions</h3><div>Observed associations between religious service attendance, vaccine attitudes, and trust in the Centers for Disease Control and Prevention encourage meaningfully redefining public health and faith community partnerships oriented toward COVID-19–related education and disease prevention.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 5","pages":"Article 100404"},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144889872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Opioid Dosage Tapering and Opioid Overdose Among Long-Term Higher-Dose Opioid Users 长期高剂量阿片类药物使用者中阿片类药物剂量逐渐减少与阿片类药物过量之间的关系
Pub Date : 2025-07-29 DOI: 10.1016/j.focus.2025.100399
Hui Zhou PhD , Katherine J. Pak MS , Fagen Xie PhD , Craig K. Chang MD , Patricia L. Gray PharmD , Deborah S. Ling-Grant PhD , Joanna L. Barreras PhD, MSW , Steven G. Steinberg MD , Rulin C. Hechter MD, PhD

Introduction

There has been a steady decline in the national opioid-dispensing rate in recent years. However, emerging evidence that suggests that abrupt discontinuation of opioids for pain may increase overdose risk. The authors examined associations between prescribed opioid tapering and short-term risk of overdose among adults who have received a new long-term high-dose opioid prescription.

Methods

This cohort study included adults (aged ≥18 years) without cancer who were newly prescribed a long-term high-dose opioid, that is, daily dose ≥50 morphine milligram equivalents for ≥183 days, between 2013 and 2018 in Kaiser Permanente Southern California. Opioid tapering within the evaluation period (3 months after being prescribed long-term high-dose opioid) was defined as a reduction ≥10% in monthly morphine milligram equivalents for at least 2 consecutive months compared with baseline morphine milligram equivalents. The association of opioid tapering with incident opioid overdose within 12 months was examined separately using multivariable Cox proportional hazard models with inverse probability of treatment weight. Sensitivity analyses were performed to differentiate the association by tapering rates.

Results

Among 12,866 eligible individuals, 7,372 (57.3%) initiated tapering within 3 months. Seventy-five patients had a documented opioid overdose event within 12 months during follow-up, resulting in an incidence rate of 0.022 and 0.013 event per 1,000 person-years, respectively, among the nontapered and tapered cohorts. Tapering within the evaluation period was associated with a 0.48 (hazard ratio=0.52; 95% CI=0.33, 0.82) reduction in risk of overdose in the subsequent 12 months. Sensitivity analyses suggested that a tapering rate of 20%–40% reduction monthly was associated with lower risk.

Conclusions

Among patients newly prescribed long-term high-dose opioids, initiating tapering within 3 months was shown to be associated with reduced short-term risk of opioid overdose. However, more studies are needed for further confirmation.
近年来,全国阿片类药物配药率稳步下降。然而,新出现的证据表明,突然停止阿片类药物治疗疼痛可能会增加过量的风险。作者研究了在接受新的长期高剂量阿片类药物处方的成年人中,处方阿片类药物逐渐减少与短期过量风险之间的关系。方法:该队列研究纳入了2013年至2018年间在南加州凯撒医疗机构(Kaiser Permanente Southern California)新开长期高剂量阿片类药物(即每日剂量≥50吗啡毫克当量,持续≥183天)的无癌症成人(年龄≥18岁)。在评估期内(长期高剂量阿片类药物处方后3个月)阿片类药物逐渐减少的定义是,与基线吗啡毫克当量相比,至少连续2个月每月吗啡毫克当量减少≥10%。使用治疗重量逆概率的多变量Cox比例风险模型,分别检查阿片类药物逐渐减少与12个月内阿片类药物过量事件的关系。进行敏感性分析,通过逐渐变细率来区分两者之间的关联。结果12866名符合条件的个体中,7372人(57.3%)在3个月内开始减持。在随访期间,75名患者在12个月内发生了记录在案的阿片类药物过量事件,在非锥形队列和锥形队列中,发生率分别为0.022和0.013 / 1000人年。在评估期内逐渐减少与随后12个月过量用药风险降低0.48(风险比=0.52;95% CI=0.33, 0.82)相关。敏感性分析表明,每月减少20%-40%的减量率与较低的风险相关。结论在新开长期大剂量阿片类药物的患者中,在3个月内开始减量与阿片类药物过量的短期风险降低有关。然而,需要更多的研究来进一步证实。
{"title":"Association Between Opioid Dosage Tapering and Opioid Overdose Among Long-Term Higher-Dose Opioid Users","authors":"Hui Zhou PhD ,&nbsp;Katherine J. Pak MS ,&nbsp;Fagen Xie PhD ,&nbsp;Craig K. Chang MD ,&nbsp;Patricia L. Gray PharmD ,&nbsp;Deborah S. Ling-Grant PhD ,&nbsp;Joanna L. Barreras PhD, MSW ,&nbsp;Steven G. Steinberg MD ,&nbsp;Rulin C. Hechter MD, PhD","doi":"10.1016/j.focus.2025.100399","DOIUrl":"10.1016/j.focus.2025.100399","url":null,"abstract":"<div><h3>Introduction</h3><div>There has been a steady decline in the national opioid-dispensing rate in recent years. However, emerging evidence that suggests that abrupt discontinuation of opioids for pain may increase overdose risk. The authors examined associations between prescribed opioid tapering and short-term risk of overdose among adults who have received a new long-term high-dose opioid prescription.</div></div><div><h3>Methods</h3><div>This cohort study included adults (aged ≥18 years) without cancer who were newly prescribed a long-term high-dose opioid, that is, daily dose ≥50 morphine milligram equivalents for ≥183 days, between 2013 and 2018 in Kaiser Permanente Southern California. Opioid tapering within the evaluation period (3 months after being prescribed long-term high-dose opioid) was defined as a reduction ≥10% in monthly morphine milligram equivalents for at least 2 consecutive months compared with baseline morphine milligram equivalents. The association of opioid tapering with incident opioid overdose within 12 months was examined separately using multivariable Cox proportional hazard models with inverse probability of treatment weight. Sensitivity analyses were performed to differentiate the association by tapering rates.</div></div><div><h3>Results</h3><div>Among 12,866 eligible individuals, 7,372 (57.3%) initiated tapering within 3 months. Seventy-five patients had a documented opioid overdose event within 12 months during follow-up, resulting in an incidence rate of 0.022 and 0.013 event per 1,000 person-years, respectively, among the nontapered and tapered cohorts. Tapering within the evaluation period was associated with a 0.48 (hazard ratio=0.52; 95% CI=0.33, 0.82) reduction in risk of overdose in the subsequent 12 months. Sensitivity analyses suggested that a tapering rate of 20%–40% reduction monthly was associated with lower risk.</div></div><div><h3>Conclusions</h3><div>Among patients newly prescribed long-term high-dose opioids, initiating tapering within 3 months was shown to be associated with reduced short-term risk of opioid overdose. However, more studies are needed for further confirmation.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 6","pages":"Article 100399"},"PeriodicalIF":0.0,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145159442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program 2型糖尿病预防的现实世界干预(REALITY):一项评估国家糖尿病预防计划的有效性和成本效益的多地点研究
Pub Date : 2025-07-29 DOI: 10.1016/j.focus.2025.100401
William H. Herman MD , Benjamin D. Tyndall PhD , O. Kenrik Duru MD , Tannaz Moin MD , Laura N. McEwen PhD , Hui Shao PhD , Ronald T. Ackermann MD , Sara R. Jacobs PhD , Simon Neuwahl MS , Shihchen Kuo PhD , Ping Zhang PhD , Meda E. Pavkov MD , Claudia Villatoro Santos MD, Phd , REALITY Network

Introduction

The National Diabetes Prevention Program was created on the basis of evidence from landmark clinical trials. Its format was modified to facilitate real-world delivery. The long-term effectiveness and cost-effectiveness of the National Diabetes Prevention Program and similar lifestyle change programs in real-world settings remain largely unknown. The Centers for Disease Control and Prevention issued a request for proposals to establish and fund a research network to determine the long-term effectiveness of the National Diabetes Prevention Program in reducing Type 2 diabetes incidence, improving cardiovascular disease risk factors and health-related quality of life, and reducing healthcare service utilization and costs.

Methods

Researchers at the University of California Los Angeles, Northwestern University, the University of Michigan, and Emory University, with a coordinating center at RTI International, were funded to examine incident Type 2 diabetes and cardiovascular disease risk factors among a diverse group of National Diabetes Prevention Program and MOVE! enrollees and nonenrollees using electronic health record and administrative claims data. The network will also assess health utility scores by conducting a health-related quality of life survey; examine healthcare utilization, costs, and cost-effectiveness of the National Diabetes Prevention Program and MOVE! for diabetes prevention; and assess the costs of delivering these programs.

Results

The study sites have collaborated with RTI and Centers for Disease Control and Prevention to develop common core data elements and standardized study procedures to ensure that each site collects data that can be harmonized across sites.

Conclusions

The results of this research will address the objectives of Healthy People 2030; help define the longer-term real-world effectiveness of the National Diabetes Prevention Program; and guide the resources needed to provide and improve program accessibility, sustainability, and effectiveness and improve population-level outcomes.
国家糖尿病预防计划是在具有里程碑意义的临床试验证据的基础上建立的。它的格式被修改,以方便实际交付。国家糖尿病预防计划和类似的生活方式改变计划在现实世界中的长期有效性和成本效益仍然很大程度上未知。美国疾病控制和预防中心发布了一项提案,要求建立并资助一个研究网络,以确定国家糖尿病预防计划在降低2型糖尿病发病率、改善心血管疾病风险因素和与健康相关的生活质量、降低医疗服务利用率和成本方面的长期有效性。方法加州大学洛杉矶分校、西北大学、密歇根大学和埃默里大学的研究人员,以及RTI国际的一个协调中心,得到资助,在不同的国家糖尿病预防计划和MOVE!使用电子健康记录和行政索赔数据的登记人和非登记人。该网络还将通过开展与健康有关的生活质量调查来评估健康效用得分;检查医疗保健的利用,成本和成本效益的国家糖尿病预防计划和移动!预防糖尿病;并评估提供这些项目的成本。结果研究站点与RTI和疾病控制与预防中心合作,制定了共同的核心数据元素和标准化研究程序,以确保每个站点收集的数据可以在站点之间进行协调。结论本研究的结果将有助于实现“健康人群2030”的目标;帮助确定国家糖尿病预防计划的长期实际有效性;指导提供和改善项目可及性、可持续性和有效性所需的资源,并改善人口层面的成果。
{"title":"Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program","authors":"William H. Herman MD ,&nbsp;Benjamin D. Tyndall PhD ,&nbsp;O. Kenrik Duru MD ,&nbsp;Tannaz Moin MD ,&nbsp;Laura N. McEwen PhD ,&nbsp;Hui Shao PhD ,&nbsp;Ronald T. Ackermann MD ,&nbsp;Sara R. Jacobs PhD ,&nbsp;Simon Neuwahl MS ,&nbsp;Shihchen Kuo PhD ,&nbsp;Ping Zhang PhD ,&nbsp;Meda E. Pavkov MD ,&nbsp;Claudia Villatoro Santos MD, Phd ,&nbsp;REALITY Network","doi":"10.1016/j.focus.2025.100401","DOIUrl":"10.1016/j.focus.2025.100401","url":null,"abstract":"<div><h3>Introduction</h3><div>The National Diabetes Prevention Program was created on the basis of evidence from landmark clinical trials. Its format was modified to facilitate real-world delivery. The long-term effectiveness and cost-effectiveness of the National Diabetes Prevention Program and similar lifestyle change programs in real-world settings remain largely unknown. The Centers for Disease Control and Prevention issued a request for proposals to establish and fund a research network to determine the long-term effectiveness of the National Diabetes Prevention Program in reducing Type 2 diabetes incidence, improving cardiovascular disease risk factors and health-related quality of life, and reducing healthcare service utilization and costs.</div></div><div><h3>Methods</h3><div>Researchers at the University of California Los Angeles, Northwestern University, the University of Michigan, and Emory University, with a coordinating center at RTI International, were funded to examine incident Type 2 diabetes and cardiovascular disease risk factors among a diverse group of National Diabetes Prevention Program and MOVE! enrollees and nonenrollees using electronic health record and administrative claims data. The network will also assess health utility scores by conducting a health-related quality of life survey; examine healthcare utilization, costs, and cost-effectiveness of the National Diabetes Prevention Program and MOVE! for diabetes prevention; and assess the costs of delivering these programs.</div></div><div><h3>Results</h3><div>The study sites have collaborated with RTI and Centers for Disease Control and Prevention to develop common core data elements and standardized study procedures to ensure that each site collects data that can be harmonized across sites.</div></div><div><h3>Conclusions</h3><div>The results of this research will address the objectives of <em>Healthy People 2030</em>; help define the longer-term real-world effectiveness of the National Diabetes Prevention Program; and guide the resources needed to provide and improve program accessibility, sustainability, and effectiveness and improve population-level outcomes.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 6","pages":"Article 100401"},"PeriodicalIF":0.0,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145333279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allostatic Load Patterns by U.S. Citizenship Status and Length of U.S. Residency Among Adults, 2009–2018 2009-2018年成年人美国公民身份和美国居住时间的适应负荷模式
Pub Date : 2025-07-29 DOI: 10.1016/j.focus.2025.100400
Kazumi Tsuchiya PhD , Harry O. Taylor PhD , Shakira F. Suglia ScD , Michael D. Niño PhD , Patricia O’Campo PhD , Ryan T. Demmer PhD

Introduction

Emerging research has documented that having a non-citizen status (e.g., temporary visa, undocumented) induces stress and, as a result, has adverse impacts on health. It is unclear whether chronic stress differs by citizenship status and length of U.S. residency using clinical biomarkers. The objective of this study was to examine allostatic load (or cumulative stress) by citizenship status and length of U.S. residency among U.S. adults.

Methods

The study sample included 27,705 adult respondents (aged ≥20 years) from the 2009–2018 National Health and Nutrition Examination Surveys. Multivariable Poisson regression models were estimated with U.S. citizenship status (U.S.-born citizens, naturalized citizens, noncitizens) and U.S. residency (shorter: <15 years, longer: ≥15 years) on allostatic load. Allostatic load was defined with summative scores of 10 biomarkers (systolic blood pressure, diastolic blood pressure, high-density lipoprotein, total cholesterol, HbA1c, BMI, albumin, estimated glomerular filtration rate, white blood cell count, and asthma).

Results

Naturalized citizens with shorter U.S. residency (females only) and noncitizens with shorter U.S. residency had lower allostatic load than U.S.-born citizens. Naturalized citizens with longer U.S. residency had greater allostatic load than naturalized citizens with shorter U.S. residency (females only). Noncitizens with longer U.S. residency had higher allostatic load than both noncitizens with shorter U.S. residency and naturalized citizens with shorter U.S. residency (females only).

Conclusions

This study demonstrates nuanced impacts on allostatic load by citizenship status and length of U.S. residency, with differences by sex. The findings infer that citizenship status contributes to health inequities among immigrants, with greater attention needed to unpack citizenship-stress mechanisms.
新出现的研究表明,拥有非公民身份(例如临时签证、无证件)会导致压力,从而对健康产生不利影响。目前尚不清楚慢性压力是否因公民身份和美国居住时间长短而不同。本研究的目的是通过美国公民身份和美国居住时间长短来检验美国成年人的适应负荷(或累积压力)。方法选取2009-2018年全国健康与营养调查的27,705名年龄≥20岁的成年人作为研究对象。用美国公民身份(美国出生的公民、归化公民、非公民)和美国居住权(较短:15年,较长:≥15年)对适应负荷进行多变量泊松回归模型估计。采用10项生物标志物(收缩压、舒张压、高密度脂蛋白、总胆固醇、HbA1c、BMI、白蛋白、估计肾小球滤过率、白细胞计数和哮喘)的总合评分来定义适应负荷。结果在美国居住时间较短的入籍公民(仅限女性)和居住时间较短的非美国公民的适应负荷低于在美国出生的公民。在美国居住时间较长的入籍公民比在美国居住时间较短的入籍公民有更大的适应负荷(仅限女性)。居住时间较长的非美国公民的适应负荷高于居住时间较短的非美国公民和居住时间较短的归化公民(仅限女性)。本研究表明国籍和在美居住时间长短对适应负荷有细微的影响,性别差异较大。研究结果表明,公民身份导致了移民之间的健康不平等,需要更多的关注来解开公民身份压力机制。
{"title":"Allostatic Load Patterns by U.S. Citizenship Status and Length of U.S. Residency Among Adults, 2009–2018","authors":"Kazumi Tsuchiya PhD ,&nbsp;Harry O. Taylor PhD ,&nbsp;Shakira F. Suglia ScD ,&nbsp;Michael D. Niño PhD ,&nbsp;Patricia O’Campo PhD ,&nbsp;Ryan T. Demmer PhD","doi":"10.1016/j.focus.2025.100400","DOIUrl":"10.1016/j.focus.2025.100400","url":null,"abstract":"<div><h3>Introduction</h3><div>Emerging research has documented that having a non-citizen status (e.g., temporary visa, undocumented) induces stress and, as a result, has adverse impacts on health. It is unclear whether chronic stress differs by citizenship status and length of U.S. residency using clinical biomarkers. The objective of this study was to examine allostatic load (or cumulative stress) by citizenship status and length of U.S. residency among U.S. adults.</div></div><div><h3>Methods</h3><div>The study sample included 27,705 adult respondents (aged ≥20 years) from the 2009–2018 National Health and Nutrition Examination Surveys. Multivariable Poisson regression models were estimated with U.S. citizenship status (U.S.-born citizens, naturalized citizens, noncitizens) and U.S. residency (shorter: &lt;15 years, longer: ≥15 years) on allostatic load. Allostatic load was defined with summative scores of 10 biomarkers (systolic blood pressure, diastolic blood pressure, high-density lipoprotein, total cholesterol, HbA1c, BMI, albumin, estimated glomerular filtration rate, white blood cell count, and asthma).</div></div><div><h3>Results</h3><div>Naturalized citizens with shorter U.S. residency (females only) and noncitizens with shorter U.S. residency had lower allostatic load than U.S.-born citizens. Naturalized citizens with longer U.S. residency had greater allostatic load than naturalized citizens with shorter U.S. residency (females only). Noncitizens with longer U.S. residency had higher allostatic load than both noncitizens with shorter U.S. residency and naturalized citizens with shorter U.S. residency (females only).</div></div><div><h3>Conclusions</h3><div>This study demonstrates nuanced impacts on allostatic load by citizenship status and length of U.S. residency, with differences by sex. The findings infer that citizenship status contributes to health inequities among immigrants, with greater attention needed to unpack citizenship-stress mechanisms.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 6","pages":"Article 100400"},"PeriodicalIF":0.0,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145050065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comfort With Sharing Food Insecurity Risk for Clinical Care Among Individuals With and Without a Cancer History: Findings From a National Survey 在有或没有癌症病史的个体中分享食品不安全风险以进行临床护理:一项全国调查的结果
Pub Date : 2025-07-24 DOI: 10.1016/j.focus.2025.100395
Steven A. Benyahia BA , Johnathan Torikashvili BS , Tejasvi Paturu BA , Marian Mikhael BS , Oliver T. Nguyen MSHI , Jessica Y. Islam PhD, MPH , Amir Alishahi Tabriz MD, PhD, MPH , Young-Rock Hong PhD, MPH , Kea L. Turner PhD, MPH, MA

Introduction

Food insecurity negatively affects timely access to care, treatment adherence, quality of life, and survival among cancer survivors. There is limited knowledge about cancer survivors’ comfort with sharing food insecurity risk for clinical care on a national scale. This study aims to assess comfort with sharing food insecurity risk for clinical care among adults with and without a cancer history and to identify factors that may be associated with comfort for sharing food insecurity risk.

Methods

Data were obtained from the National Cancer Institute’s Health Information National Trends Survey 6, which was administered from March 7, 2022, to November 8, 2022. Descriptive statistics were calculated to describe the study sample, and sample characteristics were compared by comfort with sharing food insecurity risk for clinical care. A multivariable logistic regression model was conducted to estimate the probability of comfort with sharing food insecurity risk for clinical care. Full-sample weights were applied to calculate population-level estimates, and jackknife replicate weights were applied to calculate SEs.

Results

The weighted sample included 188,146,395 participants (6.7% were cancer survivors). Overall, most cancer survivors (64.9%) and adults without a cancer history (58.7%) reported comfort with sharing food insecurity risk for clinical care. Controlling other factors, cancer survivors reported a similar comfort level with sharing food insecurity risk (OR=1.33; 95% CI=0.97, 1.80) compared to individuals without a cancer history. Controlling other factors, individuals reporting at or above the mean patient-centered communication (OR=1.52; 95% CI=1.24, 1.87) were more likely to report comfort with sharing food insecurity risk than individuals reporting below the mean patient-centered communication. Individuals experiencing food insecurity reported a similar comfort level with sharing food insecurity risk (OR=0.93; 95% CI=0.5, 1.31) compared to adults not experiencing food insecurity.

Conclusions

Study findings suggest that screening for food insecurity risk may be acceptable to cancer survivors and that patient-centered communication may support participation in food insecurity screening. Future studies are needed to assess cancer survivors’ preferences for sharing food insecurity risk for clinical care (what, when, where, and how data are shared) to ensure that implementation is aligned with patient preferences.
粮食不安全对癌症幸存者及时获得护理、坚持治疗、生活质量和生存产生负面影响。关于癌症幸存者是否愿意在全国范围内分担粮食不安全风险以进行临床护理的知识有限。本研究旨在评估有和没有癌症病史的成年人在临床护理中分担食品不安全风险的舒适度,并确定可能与分担食品不安全风险的舒适度相关的因素。方法数据来自国家癌症研究所的健康信息国家趋势调查6,该调查于2022年3月7日至2022年11月8日进行。计算描述性统计来描述研究样本,并通过分享临床护理食品不安全风险的舒适度来比较样本特征。采用多变量logistic回归模型来估计临床护理中共享食品不安全风险的舒适概率。采用全样本权值计算总体水平估计值,采用叠刀重复权值计算se。结果加权样本包括188,146,395名参与者(6.7%为癌症幸存者)。总体而言,大多数癌症幸存者(64.9%)和没有癌症病史的成年人(58.7%)表示愿意分担食品不安全风险以进行临床护理。在控制了其他因素后,与没有癌症病史的个体相比,癌症幸存者报告了相似的食物不安全风险分担舒适度(OR=1.33; 95% CI=0.97, 1.80)。控制其他因素后,报告达到或高于以患者为中心的平均沟通水平的个体(or =1.52; 95% CI=1.24, 1.87)比报告低于以患者为中心的平均沟通水平的个体更有可能报告对分享食品不安全风险感到舒适。与没有经历粮食不安全的成年人相比,经历粮食不安全的个人报告了相似的粮食不安全风险分担舒适度(OR=0.93; 95% CI=0.5, 1.31)。研究结果表明,癌症幸存者可以接受食品不安全风险筛查,以患者为中心的沟通可能有助于参与食品不安全筛查。未来的研究需要评估癌症幸存者在临床护理中分享粮食不安全风险的偏好(什么、何时、何地以及如何共享数据),以确保实施与患者的偏好保持一致。
{"title":"Comfort With Sharing Food Insecurity Risk for Clinical Care Among Individuals With and Without a Cancer History: Findings From a National Survey","authors":"Steven A. Benyahia BA ,&nbsp;Johnathan Torikashvili BS ,&nbsp;Tejasvi Paturu BA ,&nbsp;Marian Mikhael BS ,&nbsp;Oliver T. Nguyen MSHI ,&nbsp;Jessica Y. Islam PhD, MPH ,&nbsp;Amir Alishahi Tabriz MD, PhD, MPH ,&nbsp;Young-Rock Hong PhD, MPH ,&nbsp;Kea L. Turner PhD, MPH, MA","doi":"10.1016/j.focus.2025.100395","DOIUrl":"10.1016/j.focus.2025.100395","url":null,"abstract":"<div><h3>Introduction</h3><div>Food insecurity negatively affects timely access to care, treatment adherence, quality of life, and survival among cancer survivors. There is limited knowledge about cancer survivors’ comfort with sharing food insecurity risk for clinical care on a national scale. This study aims to assess comfort with sharing food insecurity risk for clinical care among adults with and without a cancer history and to identify factors that may be associated with comfort for sharing food insecurity risk.</div></div><div><h3>Methods</h3><div>Data were obtained from the National Cancer Institute’s Health Information National Trends Survey 6, which was administered from March 7, 2022, to November 8, 2022. Descriptive statistics were calculated to describe the study sample, and sample characteristics were compared by comfort with sharing food insecurity risk for clinical care. A multivariable logistic regression model was conducted to estimate the probability of comfort with sharing food insecurity risk for clinical care. Full-sample weights were applied to calculate population-level estimates, and jackknife replicate weights were applied to calculate SEs.</div></div><div><h3>Results</h3><div>The weighted sample included 188,146,395 participants (6.7% were cancer survivors). Overall, most cancer survivors (64.9%) and adults without a cancer history (58.7%) reported comfort with sharing food insecurity risk for clinical care. Controlling other factors, cancer survivors reported a similar comfort level with sharing food insecurity risk (OR=1.33; 95% CI=0.97, 1.80) compared to individuals without a cancer history. Controlling other factors, individuals reporting at or above the mean patient-centered communication (OR=1.52; 95% CI=1.24, 1.87) were more likely to report comfort with sharing food insecurity risk than individuals reporting below the mean patient-centered communication. Individuals experiencing food insecurity reported a similar comfort level with sharing food insecurity risk (OR=0.93; 95% CI=0.5, 1.31) compared to adults not experiencing food insecurity.</div></div><div><h3>Conclusions</h3><div>Study findings suggest that screening for food insecurity risk may be acceptable to cancer survivors and that patient-centered communication may support participation in food insecurity screening. Future studies are needed to assess cancer survivors’ preferences for sharing food insecurity risk for clinical care (what, when, where, and how data are shared) to ensure that implementation is aligned with patient preferences.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 5","pages":"Article 100395"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144908700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Training on Professional Development in Graduate Public Health: Preliminary Insights From a Qualitative Study of MPH Alumni Perspectives 公共卫生研究生专业发展的整合训练:从公共卫生硕士校友角度的定性研究的初步见解
Pub Date : 2025-07-23 DOI: 10.1016/j.focus.2025.100397
Yi Gao MPH , Ariz Keshwani MPH , Sumreen Akhtar BS , Leah C. Neubauer EdD, MA, CPH

Introduction

For decades, researchers, educators, and policymakers have highlighted the benefits of well-designed course assignments in graduate settings, particularly those supporting learners in applying professional development objectives. Critically reflective course assignments enable learners to practice critical thinking and bridge gaps between theoretical knowledge and practical application. Despite its significant impact on overall competency and workforce outcomes, the integration and evaluation of experiential professional development training in academic public health curricula remain underexplored.

Methods

This study examined the perspectives of 13 Master of Public Health global health alumni across 4 cohorts within a Council on Education for Public Health–accredited program. Participants provided insights into key learning outcomes, themes, and the learning impact of engaging in a threaded Professional Development Educational Event and Analysis course assignment. A pragmatic design-guided analysis approach was employed to identify recurring themes and insights.

Results

Key learning outcomes included developing the habit of seeking and participating in professional development opportunities and incorporating topics beyond the formal Master of Public Health curriculum. Alumni emphasized the practical advantages of engaging in real-world settings and reflecting on their current and future public health practice.

Conclusions

Findings suggest that incorporating innovative, active, and experiential learning opportunities, along with assignments fostering critical reflection, enhances the preparation of a competent and effective public health workforce. This approach bridges the gap between academic training and workforce readiness, offering actionable insights for curriculum development in public health education.
几十年来,研究人员、教育工作者和政策制定者都强调了在研究生环境中设计良好的课程作业的好处,特别是那些支持学习者应用专业发展目标的课程作业。批判性反思的课程作业使学习者能够练习批判性思维,弥合理论知识和实际应用之间的差距。尽管体验性专业发展培训对整体能力和劳动力产出有重大影响,但在公共卫生学术课程中整合和评估体验性专业发展培训的探索仍不足。方法:本研究调查了公共卫生教育委员会认可项目中4个队列的13名公共卫生硕士全球卫生校友的观点。参与者提供了关于关键学习成果、主题以及参与专业发展教育活动和分析课程作业的学习影响的见解。采用实用的设计指导分析方法来确定重复出现的主题和见解。结果主要学习成果包括培养寻求和参与专业发展机会的习惯,并纳入正式公共卫生硕士课程之外的主题。校友们强调了参与现实环境和反思他们当前和未来的公共卫生实践的实际优势。结论:研究结果表明,结合创新、积极和体验式的学习机会,以及培养批判性反思的作业,可以增强一支有能力和有效的公共卫生队伍的准备。这种方法弥合了学术培训和劳动力准备之间的差距,为公共卫生教育课程开发提供了可行的见解。
{"title":"Integrating Training on Professional Development in Graduate Public Health: Preliminary Insights From a Qualitative Study of MPH Alumni Perspectives","authors":"Yi Gao MPH ,&nbsp;Ariz Keshwani MPH ,&nbsp;Sumreen Akhtar BS ,&nbsp;Leah C. Neubauer EdD, MA, CPH","doi":"10.1016/j.focus.2025.100397","DOIUrl":"10.1016/j.focus.2025.100397","url":null,"abstract":"<div><h3>Introduction</h3><div>For decades, researchers, educators, and policymakers have highlighted the benefits of well-designed course assignments in graduate settings, particularly those supporting learners in applying professional development objectives. Critically reflective course assignments enable learners to practice critical thinking and bridge gaps between theoretical knowledge and practical application. Despite its significant impact on overall competency and workforce outcomes, the integration and evaluation of experiential professional development training in academic public health curricula remain underexplored.</div></div><div><h3>Methods</h3><div>This study examined the perspectives of 13 Master of Public Health global health alumni across 4 cohorts within a Council on Education for Public Health–accredited program. Participants provided insights into key learning outcomes, themes, and the learning impact of engaging in a threaded Professional Development Educational Event and Analysis course assignment. A pragmatic design-guided analysis approach was employed to identify recurring themes and insights.</div></div><div><h3>Results</h3><div>Key learning outcomes included developing the habit of seeking and participating in professional development opportunities and incorporating topics beyond the formal Master of Public Health curriculum. Alumni emphasized the practical advantages of engaging in real-world settings and reflecting on their current and future public health practice.</div></div><div><h3>Conclusions</h3><div>Findings suggest that incorporating innovative, active, and experiential learning opportunities, along with assignments fostering critical reflection, enhances the preparation of a competent and effective public health workforce. This approach bridges the gap between academic training and workforce readiness, offering actionable insights for curriculum development in public health education.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 5","pages":"Article 100397"},"PeriodicalIF":0.0,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144903195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Submaximal Exercise Testing for Metabolic Flexibility: A Possible Window Into Mitochondrial Function 代谢柔韧性的亚极限运动测试:线粒体功能的可能窗口
Pub Date : 2025-07-22 DOI: 10.1016/j.focus.2025.100398
Dale I. Lovell PhD , Max Stuelcken PhD , Alexander Eagles MD, PhD
{"title":"Submaximal Exercise Testing for Metabolic Flexibility: A Possible Window Into Mitochondrial Function","authors":"Dale I. Lovell PhD ,&nbsp;Max Stuelcken PhD ,&nbsp;Alexander Eagles MD, PhD","doi":"10.1016/j.focus.2025.100398","DOIUrl":"10.1016/j.focus.2025.100398","url":null,"abstract":"","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 5","pages":"Article 100398"},"PeriodicalIF":0.0,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144903194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical Cannabis Utilization Across States With Varying Legal Status 具有不同法律地位的各州的医用大麻使用情况
Pub Date : 2025-07-22 DOI: 10.1016/j.focus.2025.100396
Deanna Romero BS , Thomas A. Clobes PhD , Marshall M. Mee , Isaac Quintanilla Salinas PhD

Introduction

Despite increasing legalization of medical cannabis across the U.S., significant barriers to access and utilization remain, particularly in states with restrictive policies. This study aimed to explore the patterns of medical cannabis use, methods of acquisition, perceived efficacy, and barriers to use, with a focus on how these factors vary by state-level legal status.

Methods

A cross-sectional, nationwide survey was administered online during August–September 2023 to a purposefully sampled U.S. adult population. Of 2,824 respondents, 996 individuals self-identified as using cannabis for medical purposes and were included in the final analysis. Measures included demographic variables, cannabis usage patterns, therapeutic indications, perceived effectiveness, and challenges related to legal frameworks and healthcare disclosure.

Results

Cannabis use varied significantly by state legal status (chi-square=22.26, p=0.001), with 43.1% of respondents in fully legal states using medical cannabis, compared with 27% in prohibition states. Anxiety (65.9%), depression (48%), and chronic pain (37%) were the most commonly reported conditions. Participants reported diverse consumption methods, with smoking (74.3%) being the most common, although also associated with the highest rate of side effects (chi-square=216, p<0.001). Overall, 32.3% of participants rated medical cannabis as a great deal effective for their primary condition. Legal status also influenced the conditions treated: bipolar disorder was more frequently reported in prohibition states, whereas degenerative neurologic conditions were more common in legal states. Notably, 43.2% of medical cannabis users had not disclosed their use to a primary care provider. Of those, nearly 40% cited fear of provider disapproval, and 27.1% cited concerns about legality—even in states where medical cannabis was permitted. In addition, 45% of those who experienced barriers cited cost as a deterrent, and over half reported using less medical cannabis owing to these challenges.

Conclusions

The findings highlight significant variations in medical cannabis usage and associated challenges based on state legal frameworks. Barriers such as cost and fear of disclosure underscore the need for clearer communication and policy reforms to improve access and patient–provider dialog. Further research is warranted to explore the clinical implications of medical cannabis use across diverse populations.
尽管医用大麻在美国各地的合法化程度不断提高,但获取和使用方面仍然存在重大障碍,特别是在实行限制性政策的州。本研究旨在探讨医用大麻的使用模式、获取方法、感知功效和使用障碍,重点关注这些因素如何因州一级法律地位而异。方法在2023年8月至9月期间,对有目的地抽样的美国成年人进行了一项全国性的横断面在线调查。在2 824名答复者中,有996人自称为医疗目的使用大麻,并被列入最后分析。措施包括人口变量、大麻使用模式、治疗指征、感知有效性以及与法律框架和医疗保健信息披露相关的挑战。结果不同州大麻使用情况差异显著(χ 2 =22.26, p=0.001),完全合法州有43.1%的受访者使用医用大麻,禁止州有27%的受访者使用医用大麻。焦虑(65.9%)、抑郁(48%)和慢性疼痛(37%)是最常见的症状。参与者报告了不同的消费方式,吸烟(74.3%)是最常见的,尽管也与最高的副作用率相关(卡方=216,p<0.001)。总的来说,32.3%的参与者认为医用大麻对他们的原发性疾病非常有效。法律地位也影响治疗条件:双相情感障碍更频繁地报告在禁止状态,而退行性神经系统疾病更常见的法律状态。值得注意的是,43.2%的医用大麻使用者没有向初级保健提供者披露其使用情况。其中,近40%的人表示担心供应商不赞成,27.1%的人表示担心合法性——即使在允许医用大麻的州也是如此。此外,45%遇到障碍的人认为费用是一种威慑因素,一半以上的人报告说,由于这些挑战,医用大麻的使用量减少了。研究结果强调了基于各州法律框架的医用大麻使用的显著差异和相关挑战。成本和对披露的恐惧等障碍强调需要更明确的沟通和政策改革,以改善获取和患者与提供者的对话。有必要进行进一步研究,以探讨不同人群使用医用大麻的临床意义。
{"title":"Medical Cannabis Utilization Across States With Varying Legal Status","authors":"Deanna Romero BS ,&nbsp;Thomas A. Clobes PhD ,&nbsp;Marshall M. Mee ,&nbsp;Isaac Quintanilla Salinas PhD","doi":"10.1016/j.focus.2025.100396","DOIUrl":"10.1016/j.focus.2025.100396","url":null,"abstract":"<div><h3>Introduction</h3><div>Despite increasing legalization of medical cannabis across the U.S., significant barriers to access and utilization remain, particularly in states with restrictive policies. This study aimed to explore the patterns of medical cannabis use, methods of acquisition, perceived efficacy, and barriers to use, with a focus on how these factors vary by state-level legal status.</div></div><div><h3>Methods</h3><div>A cross-sectional, nationwide survey was administered online during August–September 2023 to a purposefully sampled U.S. adult population. Of 2,824 respondents, 996 individuals self-identified as using cannabis for medical purposes and were included in the final analysis. Measures included demographic variables, cannabis usage patterns, therapeutic indications, perceived effectiveness, and challenges related to legal frameworks and healthcare disclosure.</div></div><div><h3>Results</h3><div>Cannabis use varied significantly by state legal status (chi-square=22.26, <em>p</em>=0.001), with 43.1% of respondents in fully legal states using medical cannabis, compared with 27% in prohibition states. Anxiety (65.9%), depression (48%), and chronic pain (37%) were the most commonly reported conditions. Participants reported diverse consumption methods, with smoking (74.3%) being the most common, although also associated with the highest rate of side effects (chi-square=216, <em>p</em>&lt;0.001). Overall, 32.3% of participants rated medical cannabis as a great deal effective for their primary condition. Legal status also influenced the conditions treated: bipolar disorder was more frequently reported in prohibition states, whereas degenerative neurologic conditions were more common in legal states. Notably, 43.2% of medical cannabis users had not disclosed their use to a primary care provider. Of those, nearly 40% cited fear of provider disapproval, and 27.1% cited concerns about legality—even in states where medical cannabis was permitted. In addition, 45% of those who experienced barriers cited cost as a deterrent, and over half reported using less medical cannabis owing to these challenges.</div></div><div><h3>Conclusions</h3><div>The findings highlight significant variations in medical cannabis usage and associated challenges based on state legal frameworks. Barriers such as cost and fear of disclosure underscore the need for clearer communication and policy reforms to improve access and patient–provider dialog. Further research is warranted to explore the clinical implications of medical cannabis use across diverse populations.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 5","pages":"Article 100396"},"PeriodicalIF":0.0,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145010336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining Changes in Coalition Dynamics to Support Opioid Fatality Reduction 检查联盟动态变化以支持阿片类药物死亡率降低
Pub Date : 2025-07-21 DOI: 10.1016/j.focus.2025.100394
Darcy A. Freedman PhD , Hannah K. Knudsen PhD , Rouba A. Chahine PhD , Timothy Hunt PhD , Emmanuel Oga MD, MPH , Alison M. Aldrich MPH , Sara Roberts MSSA , LaShawn Glasgow DrPH , Bryan R. Garner PhD , Sylvia Tan MS , JaNae Holloway MSPH , Timothy Huerta PhD , Carol Baden , Pamela Salsberry PhD , Bridget Freisthler PhD

Introduction

The goal was to evaluate how changes in coalition capacity and leadership were related to adoption and reach of overdose education and naloxone distribution in communities participating in the HEALing Communities Study.

Study Design

This was a multisite, cluster randomized waitlist-controlled trial; only analysis of Wave 1 data was performed.

Setting/Participants

Longitudinal analysis of cross-sectional surveys completed by coalition members from 33 communities in 4 states based on data collected from January 2021 to June 2022.

Intervention

Study coalitions (n=33) received the Communities That HEAL intervention to support expansion of evidence-based practices, including overdose education and naloxone distribution, to curtail opioid-related fatalities.

Main Outcomes

Coalition capacity and leadership were measured at the midpoint and end of the intervention using validated scales averaged at the community level. Community adoption and reach of overdose education and naloxone distribution were assessed as changes in the rate of community partners implementing overdose education and naloxone distribution strategies and naloxone units distributed from midpoint to the end of the intervention. Negative binomial and linear models, adjusted for baseline characteristics, were conducted in 2024.

Results

Increases in general coalition capacity, adjusted for changes in overdose education and naloxone distribution–specific coalition capacity, were significantly associated with higher rates of community partners engaged in overdose education and naloxone distribution implementation. There was a 56% increase over time in community partners engaged in overdose education and naloxone distribution implementation per unit increase in general capacity scores among coalitions receiving Communities That HEAL. Changes in coalition leadership and capacity did not significantly correlate with changes in naloxone being distributed.

Conclusions

Strengthening general coalition capacity is vital for increasing community partner engagement to expand adoption of overdose education and naloxone distribution. Findings support ongoing investment in coalition capabilities to enhance the effectiveness of public health interventions seeking to reduce opioid-related fatalities. Efforts to strengthen general capacities of coalitions, such as data-informed decision making and collective goalsetting, may accelerate implementation and scaling of evidence-based practices such as overdose education and naloxone distribution.
目的是评估联盟能力和领导力的变化与参与康复社区研究的社区中过量用药教育和纳洛酮分发的采用和覆盖范围的关系。研究设计:这是一项多中心、集群随机等待对照试验;仅对Wave 1数据进行分析。背景/参与者根据2021年1月至2022年6月收集的数据,对来自4个州33个社区的联盟成员完成的横断面调查进行纵向分析。干预研究联盟(n=33)接受了Communities That HEAL干预,以支持扩大循证实践,包括过量教育和纳洛酮分发,以减少阿片类药物相关死亡。在干预的中点和结束时,使用在社区层面平均的有效量表来测量联盟的能力和领导力。通过社区合作伙伴实施过量教育和纳洛酮分配策略以及从干预中点到结束的纳洛酮单位分布的变化来评估过量教育和纳洛酮分配的社区采用和覆盖范围。根据基线特征调整后的负二项和线性模型于2024年进行。结果:经过量用药教育和纳洛酮分配专项联盟能力调整后,一般联盟能力的增加与参与过量用药教育和纳洛酮分配实施的社区合作伙伴比例的增加显著相关。随着时间的推移,参与过量用药教育和纳洛酮分发实施的社区合作伙伴在接受“治愈社区”的联盟中,一般能力得分每单位增加56%。联盟领导和能力的变化与纳洛酮分配的变化没有显著相关性。结论加强一般联盟能力对于提高社区合作伙伴的参与,扩大过量用药教育的采用和纳洛酮的分发至关重要。调查结果支持对联盟能力进行持续投资,以提高旨在减少阿片类药物相关死亡的公共卫生干预措施的有效性。努力加强联盟的一般能力,如基于数据的决策和集体目标设定,可能会加速实施和扩大以证据为基础的做法,如过量用药教育和纳洛酮分发。
{"title":"Examining Changes in Coalition Dynamics to Support Opioid Fatality Reduction","authors":"Darcy A. Freedman PhD ,&nbsp;Hannah K. Knudsen PhD ,&nbsp;Rouba A. Chahine PhD ,&nbsp;Timothy Hunt PhD ,&nbsp;Emmanuel Oga MD, MPH ,&nbsp;Alison M. Aldrich MPH ,&nbsp;Sara Roberts MSSA ,&nbsp;LaShawn Glasgow DrPH ,&nbsp;Bryan R. Garner PhD ,&nbsp;Sylvia Tan MS ,&nbsp;JaNae Holloway MSPH ,&nbsp;Timothy Huerta PhD ,&nbsp;Carol Baden ,&nbsp;Pamela Salsberry PhD ,&nbsp;Bridget Freisthler PhD","doi":"10.1016/j.focus.2025.100394","DOIUrl":"10.1016/j.focus.2025.100394","url":null,"abstract":"<div><h3>Introduction</h3><div>The goal was to evaluate how changes in coalition capacity and leadership were related to adoption and reach of overdose education and naloxone distribution in communities participating in the HEALing Communities Study.</div></div><div><h3>Study Design</h3><div>This was a multisite, cluster randomized waitlist-controlled trial; only analysis of Wave 1 data was performed.</div></div><div><h3>Setting/Participants</h3><div>Longitudinal analysis of cross-sectional surveys completed by coalition members from 33 communities in 4 states based on data collected from January 2021 to June 2022.</div></div><div><h3>Intervention</h3><div>Study coalitions (<em>n</em>=33) received the Communities That HEAL intervention to support expansion of evidence-based practices, including overdose education and naloxone distribution, to curtail opioid-related fatalities.</div></div><div><h3>Main Outcomes</h3><div>Coalition capacity and leadership were measured at the midpoint and end of the intervention using validated scales averaged at the community level. Community adoption and reach of overdose education and naloxone distribution were assessed as changes in the rate of community partners implementing overdose education and naloxone distribution strategies and naloxone units distributed from midpoint to the end of the intervention. Negative binomial and linear models, adjusted for baseline characteristics, were conducted in 2024.</div></div><div><h3>Results</h3><div>Increases in general coalition capacity, adjusted for changes in overdose education and naloxone distribution–specific coalition capacity, were significantly associated with higher rates of community partners engaged in overdose education and naloxone distribution implementation. There was a 56% increase over time in community partners engaged in overdose education and naloxone distribution implementation per unit increase in general capacity scores among coalitions receiving Communities That HEAL. Changes in coalition leadership and capacity did not significantly correlate with changes in naloxone being distributed.</div></div><div><h3>Conclusions</h3><div>Strengthening general coalition capacity is vital for increasing community partner engagement to expand adoption of overdose education and naloxone distribution. Findings support ongoing investment in coalition capabilities to enhance the effectiveness of public health interventions seeking to reduce opioid-related fatalities. Efforts to strengthen general capacities of coalitions, such as data-informed decision making and collective goalsetting, may accelerate implementation and scaling of evidence-based practices such as overdose education and naloxone distribution.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 6","pages":"Article 100394"},"PeriodicalIF":0.0,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145050066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Cannabis Access Laws on Sleep in the U.S. 美国大麻获取法对睡眠的影响
Pub Date : 2025-07-04 DOI: 10.1016/j.focus.2025.100387
Carol Xu BA, Zachary Sturman JD, PhD

Introduction

The global average sleep duration has declined significantly, with substantial health and economic consequences. Given the increasing legalization of cannabis for medical and recreational use, this study examines the association between cannabis access laws and sleep duration in the U.S.

Methods

A two-way-fixed-effects difference-in-differences regression was used to analyze the impact of medical and recreational cannabis laws on sleep duration. Data were drawn from the American Time Use Survey, including 175,493 respondents aged 18–65 years from 2003 to 2021. Subgroup analyses were performed on sex and age groups. Analyses were conducted in 2024.

Results

Recreational cannabis laws were associated with an average reduction in sleep of 5.37 minutes per night (99% CI=0.91, 9.83), whereas medical cannabis laws had no significant effect on sleep duration. Recreational cannabis laws were associated with individuals falling asleep 7.14 minutes later (99% CI=3.12, 11.16) with no change in wake-up times, and only the eating and drinking category of time use was significantly affected, with an increase of 1.90 minutes. These findings were concentrated in males and those aged ≥25 years.

Conclusions

The implementation of recreational cannabis laws has a negative effect on sleep duration, highlighting the need for further research on the broad impacts of cannabis access on health.
全球平均睡眠时间显著下降,对健康和经济造成重大影响。鉴于医疗和娱乐用途大麻的日益合法化,本研究考察了美国大麻获取法律与睡眠持续时间之间的关系。方法采用双向固定效应差分回归分析医疗和娱乐大麻法律对睡眠持续时间的影响。数据来自美国时间使用调查,包括2003年至2021年期间年龄在18-65岁之间的175,493名受访者。对性别和年龄组进行亚组分析。分析于2024年进行。结果娱乐性大麻法律与每晚平均睡眠减少5.37分钟相关(99% CI=0.91, 9.83),而医用大麻法律对睡眠时间没有显著影响。娱乐性大麻法律与个体晚7.14分钟入睡(99% CI=3.12, 11.16)有关,而唤醒时间没有变化,只有饮食类的时间使用受到显著影响,增加了1.90分钟。这些发现主要集中在男性和年龄≥25岁的人群中。结论娱乐性大麻法律的实施对睡眠时间有负面影响,强调需要进一步研究大麻获取对健康的广泛影响。
{"title":"The Effects of Cannabis Access Laws on Sleep in the U.S.","authors":"Carol Xu BA,&nbsp;Zachary Sturman JD, PhD","doi":"10.1016/j.focus.2025.100387","DOIUrl":"10.1016/j.focus.2025.100387","url":null,"abstract":"<div><h3>Introduction</h3><div>The global average sleep duration has declined significantly, with substantial health and economic consequences. Given the increasing legalization of cannabis for medical and recreational use, this study examines the association between cannabis access laws and sleep duration in the U.S.</div></div><div><h3>Methods</h3><div>A two-way-fixed-effects difference-in-differences regression was used to analyze the impact of medical and recreational cannabis laws on sleep duration. Data were drawn from the American Time Use Survey, including 175,493 respondents aged 18–65 years from 2003 to 2021. Subgroup analyses were performed on sex and age groups. Analyses were conducted in 2024.</div></div><div><h3>Results</h3><div>Recreational cannabis laws were associated with an average reduction in sleep of 5.37 minutes per night (99% CI=0.91, 9.83), whereas medical cannabis laws had no significant effect on sleep duration. Recreational cannabis laws were associated with individuals falling asleep 7.14 minutes later (99% CI=3.12, 11.16) with no change in wake-up times, and only the eating and drinking category of time use was significantly affected, with an increase of 1.90 minutes. These findings were concentrated in males and those aged ≥25 years.</div></div><div><h3>Conclusions</h3><div>The implementation of recreational cannabis laws has a negative effect on sleep duration, highlighting the need for further research on the broad impacts of cannabis access on health.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 5","pages":"Article 100387"},"PeriodicalIF":0.0,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145010214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AJPM focus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1